These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8664731)

  • 21. Neuroleptic drug use in the nursing home: the impact of OBRA.
    Burke WJ
    Am Fam Physician; 1991 Jun; 43(6):2125-30. PubMed ID: 1675035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in antipsychotic treatment choice across US nursing homes.
    Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
    J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.
    Kleijer BC; van Marum RJ; Frijters DH; Jansen PA; Ribbe MW; Egberts AC; Heerdink ER
    Int Psychogeriatr; 2014 Mar; 26(3):363-71. PubMed ID: 24252349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
    Fossey J; Ballard C; Juszczak E; James I; Alder N; Jacoby R; Howard R
    BMJ; 2006 Apr; 332(7544):756-61. PubMed ID: 16543297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact.
    Bronskill SE; Anderson GM; Sykora K; Wodchis WP; Gill S; Shulman KI; Rochon PA
    J Am Geriatr Soc; 2004 May; 52(5):749-55. PubMed ID: 15086656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription of neuroleptics for geriatric nursing home patients.
    Cantú TG; Korek JS
    Hosp Community Psychiatry; 1989 Jun; 40(6):645-7. PubMed ID: 2567691
    [No Abstract]   [Full Text] [Related]  

  • 29. Antipsychotics and dementia: a troubling mix.
    Jacobson J
    Am J Nurs; 2008 Dec; 108(12):20-1. PubMed ID: 19033900
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipsychotic drug prescription rates among Dutch nursing homes: the influence of patient characteristics and the dementia special care unit.
    van der Putten MJ; Wetzels RB; Bor H; Zuidema SU; Koopmans RT
    Aging Ment Health; 2014 Sep; 18(7):828-32. PubMed ID: 24506695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period.
    Szczepura A; Wild D; Khan AJ; Owen DW; Palmer T; Muhammad T; Clark MD; Bowman C
    BMJ Open; 2016 Sep; 6(9):e009882. PubMed ID: 27650756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic prescribing in dementia patients in care homes: proactive in-reach service improved quality of care.
    Chakraborty A; Linton CR
    Int J Geriatr Psychiatry; 2012 Oct; 27(10):1097-8. PubMed ID: 22945348
    [No Abstract]   [Full Text] [Related]  

  • 33. Antipsychotics in nursing homes.
    Salzman C
    J Clin Psychopharmacol; 2013 Feb; 33(1):1-2. PubMed ID: 23277258
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipsychotics for dementia: Antipsychotic prescribing in care homes.
    Bowman CE
    BMJ; 2008 Jul; 337():a895. PubMed ID: 18647769
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.
    Garrard J; Makris L; Dunham T; Heston LL; Cooper S; Ratner ER; Zelterman D; Kane RL
    JAMA; 1991 Jan 23-30; 265(4):463-7. PubMed ID: 1670645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
    Kamble P; Sherer J; Chen H; Aparasu R
    Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drug use in nursing home residents with and without dementia: keep an eye on the pro re nata medication.
    Allers K; Dörks M; Schmiemann G; Hoffmann F
    Int Clin Psychopharmacol; 2017 Jul; 32(4):213-218. PubMed ID: 28346296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in nursing home antipsychotic prescribing rates.
    Rochon PA; Stukel TA; Bronskill SE; Gomes T; Sykora K; Wodchis WP; Hillmer M; Kopp A; Gurwitz JH; Anderson GM
    Arch Intern Med; 2007 Apr; 167(7):676-83. PubMed ID: 17420426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia.
    Huber M; Kölzsch M; Rapp MA; Wulff I; Kalinowski S; Bolbrinker J; Hofmann W; Scholze J; Dräger D; Kreutz R
    Pharmacopsychiatry; 2012 Jul; 45(5):182-8. PubMed ID: 22430201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The quality of antipsychotic drug prescribing in nursing homes.
    Briesacher BA; Limcangco MR; Simoni-Wastila L; Doshi JA; Levens SR; Shea DG; Stuart B
    Arch Intern Med; 2005 Jun; 165(11):1280-5. PubMed ID: 15956008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.